← FDA DRUG APPROVALS

FDA ANDA · ANDA065490

VANCOMYCIN HYDROCHLORIDE

Sponsor: STRIDES PHARMA

APPLICATION
ANDA065490
TYPE
ANDA
ORIGINAL APPROVAL
2012-04-09
LATEST ACTION
2024-03-06
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

VANCOMYCIN HYDROCHLORIDEPrescription
VANCOMYCIN HYDROCHLORIDE EQ 125MG BASE · CAPSULE · ORAL
VANCOMYCIN HYDROCHLORIDEPrescription
VANCOMYCIN HYDROCHLORIDE EQ 250MG BASE · CAPSULE · ORAL

Approval history

2024-03-06Labeling · Supplement 15 · standardAP
2024-03-06Labeling · Supplement 16 · standardAP
2024-03-06Labeling · Supplement 14 · standardAP
2019-05-03Manufacturing (CMC) · Supplement 10 · standardAP
2012-04-09OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →